Virtual screening of cathepsin k inhibitors using docking and pharmacophore models.
Cathepsin K is a lysosomal cysteine protease that is highly and selectively expressed in osteoclasts, the cells which degrade bone during the continuous cycle of bone degradation and formation. Inhibition of cathepsin K represents a potential therapeutic approach for diseases characterized by excessive bone resorption such as osteoporosis. In order to elucidate the essential structural features for cathepsin K, a three-dimensional pharmacophore hypotheses were built on the basis of a set of known cathepsin K inhibitors selected from the literature using catalyst program. Several methods are used in validation of pharmacophore hypothesis were presented, and the fourth hypothesis (Hypo4) was considered to be the best pharmacophore hypothesis which has a correlation coefficient of 0.944 with training set and has high prediction of activity for a set of 30 test molecules with correlation of 0.909. The model (Hypo4) was then employed as 3D search query to screen the Maybridge database containing 59,000 compounds, to discover novel and highly potent ligands. For analyzing intermolecular interactions between protein and ligand, all the molecules were docked using Glide software. The result showed that the type and spatial location of chemical features encoded in the pharmacophore are in full agreement with the enzyme inhibitor interaction pattern identified from molecular docking.
Ravikumar
Muttineni
M
BioCampus, GVK Biosciences, Biocampus, Hyderabad, India. ravmbio@gmail.com
Pavan
S
S
Bairy
Santhosh
S
Pramod
A B
AB
Sumakanth
M
M
Kishore
Madala
M
Sumithra
Tirunagaram
T
D056657:Cathepsin K; D002403:Cathepsins / Q000037:antagonists & inhibitors*; D003198:Computer Simulation; D004353:Drug Evaluation, Preclinical / Q000379:methods*; D004791:Enzyme Inhibitors / Q000737:chemistry; D008958:Models, Molecular; D011485:Protein Binding
D004791:Enzyme Inhibitors; D002403:Cathepsins; D056657:Cathepsin K